This Biotech ETF Is Proxy For Broader Market's Performance

Published 08/08/2016, 10:25 AM
Updated 07/09/2023, 06:31 AM

If you bought Bio-Tech ETF IBB last summer, you've been none too pleased. That's because between July 2015 and June 2016, IBB had lost over a third of its value.

iShares Nasdaq Biotechnology

During the past 9 years, IBB has been inside rising channel (A), until it managed to break out in 2013 when it embarked on a 2-year rally. It peaked last July, when it came back down to test old channel resistance as new support at (1) several different times.

So far, rising channel support (A) has held.

Now IBB is trying a break out at (2) above. Further price appreciation at (2) will be good news for both IBB and the broader market.

What IBB does in the next few weeks -- can it breakout? -- should tell us a good deal about this leader. If it continues higher, it will send a positive price message to the risk-on trade.

It'll be important for IBB to stay above the top channel line (A) going forward.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.